Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 10/20 | 0.54 |
| ▸ | GLA | P06280 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.44 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.44 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.44 |
| ▸ | MMP1 | P03956 | 1/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.44 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | SLC47A2 | Q86VL8 | 1/20 | 0.44 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18774811 | 0.95 | TOP1 (0.54) | TOP1GLAGAACYP3A4SLC22A2 | |
| SCHEMBL18774814 | 0.95 | TOP1 (0.54) | TOP1GLAGAACYP3A4SLC22A2 | |
| SCHEMBL18774805 | 0.94 | TOP1 (0.54) | TOP1GLAGAACYP3A4SLC22A2 | |
| SCHEMBL18782739 | 0.92 | TOP1 (0.52) | TOP1GLAGAACYP3A4SLC22A2 | |
| SCHEMBL18774812 | 0.92 | TOP1 (0.52) | TOP1GLAGAACYP3A4SLC22A2 | |
| SCHEMBL20807092 | 0.92 | GLA (0.55) | TOP1GLAGAACYP3A4SLC22A2 | |
| SCHEMBL24062788 | 0.91 | TOP1 (0.53) | TOP1GLAGAACYP3A4SLC22A2 | |
| SCHEMBL20807093 | 0.89 | TOP1 (0.55) | TOP1GLAGAACYP3A4SLC22A2 | |
| SCHEMBL20807126 | 0.88 | GLA (0.55) | TOP1GLAGAACYP3A4SLC22A2 | |
| SCHEMBL18774807 | 0.88 | GLA (0.55) | TOP1GLAGAACYP3A4SLC22A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190077813-A1 | PODOPHYLLOTOXIN DERIVATIVES AND THEIR USE | CALIFORNIA PACIFIC MEDICAL CENTER (US) | 2019-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190077813-A1 | PODOPHYLLOTOXIN DERIVATIVES AND THEIR USE | CCNT2, CCNT1, CCNY | TOP1 1486/4885GLA 1854/4885GAA 4657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.